Literature DB >> 20160434

Effects of interleukin-6 on depression risk in dialysis patients.

Makrouhi Sonikian1, Polyxeni Metaxaki, Dimitrios Papavasileiou, Fotini Boufidou, Chrysoula Nikolaou, Dimosthenis Vlassopoulos, Demetrios V Vlahakos.   

Abstract

BACKGROUND/AIMS: Depression represents the most frequent psychiatric disorder in nephrology. Cytokines, and especially IL-6, were found to be elevated in depressed patients with normal renal function. The objective of this pilot study was to examine the relationship between depression and cytokines (IL-6, TNF-alpha, and IL-10) in patients with end-stage kidney disease (ESKD).
METHODS: We studied 44 stable patients with ESKD for 71 +/- 66 months (32 males; 64 +/- 13 years; 27 on hemodialysis and 17 on peritoneal dialysis). The control group included 20 healthy age- and gender-matched individuals (12 males; 60 +/- 12 years). Depression was assessed by the Zung Self-Rating Depression Scale (ZS). Nephelometry for high-sensitivity CRP and ELISA kits for IL-6, IL-10 and TNF-alpha were used.
RESULTS: Compared to controls, patients with ESKD had higher ZS scores (56.8 +/- 16.8 vs. 44 +/- 12.7, p < 0.01), WBC (7,987 +/- 2,347 vs. 6,413 +/- 870/mm(3), p < 0.01), ESR (36.3 +/- 15.8 vs. 9.4 +/- 3.3 mm, p < 0.001), TNF-alpha (52 +/- 18.4 vs. 10.7 +/- 2.8 pg/ml, p < 0.001) and IL-6 (6.3 +/- 4 vs. 1.8 +/- 0.4 pg/ml, p < 0.001). No differences in high-sensitivity CRP and IL-10 were noted between the ESKD and control groups. Serum IL-6 levels were the only parameter positively correlated with the values of the ZS score in ESKD patients (r = 0.34, p < 0.02).
CONCLUSIONS: IL-6 may play a role in the pathogenesis of depression in patients with ESKD. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160434     DOI: 10.1159/000285110

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

1.  Is inflammation a new risk factor of depression in haemodialysis patients?

Authors:  Łukasz Nowak; Marcin Adamczak; Andrzej Więcek
Journal:  Int Urol Nephrol       Date:  2012-09-13       Impact factor: 2.370

Review 2.  Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management.

Authors:  Shayan Shirazian; Candace D Grant; Olufemi Aina; Joseph Mattana; Farah Khorassani; Ana C Ricardo
Journal:  Kidney Int Rep       Date:  2016-09-20

3.  -572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease.

Authors:  A Panayides; A Ioakeimidou; V Karamouzos; N Antonakos; I Koutelidakis; G Giannikopoulos; K Makaritsis; N Voloudakis; K Toutouzas; N Rovina; M Bristianou; G Damoraki; C Routsi; E J Giamarellos-Bourboulis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-10       Impact factor: 3.267

4.  A Systematic Review and Meta-Analysis of Depression and Protein-Energy Wasting in Kidney Disease.

Authors:  L Parker Gregg; Thomas Carmody; Dustin Le; Gerard Martins; Madhukar Trivedi; S Susan Hedayati
Journal:  Kidney Int Rep       Date:  2019-12-21

5.  Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment.

Authors:  Zaher Armaly; Joseph Farah; Adel Jabbour; Bishara Bisharat; Amir Abd-El Qader; Shahira Saba; Maha Zaher; Elia El Haj; Munir Hamzi; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-25       Impact factor: 2.570

Review 6.  Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients.

Authors:  Stefania S Grigoriou; Christina Karatzaferi; Giorgos K Sakkas
Journal:  Health Psychol Res       Date:  2015-04-13

7.  Assigning Clinical Significance and Symptom Severity Using the Zung Scales: Levels of Misclassification Arising from Confusion between Index and Raw Scores.

Authors:  Debra A Dunstan; Ned Scott
Journal:  Depress Res Treat       Date:  2018-01-21

8.  Incidence and risk factors of depressive symptoms in 4 years of follow-up among mid-aged and elderly community-dwelling Chinese adults: findings from the China Health and Retirement Longitudinal Study.

Authors:  Yue Wen; Chunjuan Liu; Jing Liao; Yiqiong Yin; Dongmei Wu
Journal:  BMJ Open       Date:  2019-09-09       Impact factor: 2.692

Review 9.  Role of Interleukin-6 in Depressive Disorder.

Authors:  Emily Yi-Chih Ting; Albert C Yang; Shih-Jen Tsai
Journal:  Int J Mol Sci       Date:  2020-03-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.